Skip to main content

MoneyWorks4Me

Hester Biosciences informs about board meeting

24 Jan 2024 Evaluate
Hester Biosciences has informed that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 to consider and approve standalone and consolidated unaudited financial results for the quarter and nine months period ended 31 December 2023.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1771.95
Dr. Reddys Labs. 1370.00
Cipla 1392.20
Lupin 2012.00
Zydus Lifesciences 1239.00
View more..